What is your preferred treatment for patients with painful gynecomastia on anti-androgen therapy for prostate cancer?

Gynecomastia can be a significant morbidity affecting the quality of life in patients on androgen deprivation therapy, especially in patients who receive bicalutamide as monotherapy or at higher doses such as 150 mg a day. In patients who are younger and/or who may spend time in public without their...